Rep. Youthful Kim, R-Calif., phone calls for laws to prolong deadline for PPP mortgage applications by way of the close of Could. As Congress considers
Tag: Financial
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020
FDA Type C meeting communications support plans to initiate Phase 2 in Q2 with NM-002 for short bowel syndrome (SBS) using Total Stool Output (TSO)
VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update
Conference call to discuss financial and operational results scheduled for Tuesday, March 23 at 8:00 a.m. U.S. Eastern Time Launched first product, the Nu.Q® Vet
Youngevity International, Inc. Provides Financial Reporting and Business Update
SAN DIEGO, March 22, 2021 /PRNewswire/ — Youngevity International, Inc. (OTCMKTS: YGYI), a multi-channel lifestyle company operating in three distinct business segments, including a commercial
Wall Road closing lower financial institution shares drop | Company & Finance
Wall Street shut out a choppy 7 days of trading Friday with key stock indexes mostly decrease and all ending in the purple for the
Metro Detroit Black Company Alliance launches with $1 million from TCF Financial institution
A new collective amplifying the voices of Black small business homeowners is forming in metro Detroit, backed with $1 million from TCF Bank. Former metropolis
Celsion Corporation Reports 2020 Financial Results and Provides Business Update
Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins at 11:00 a.m. Eastern Time
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through
Ocugen Provides Business Update and Full Year 2020 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET COVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy of 81% in Phase 3 interim results Emergency Use Authorization
SQZ Biotechnologies Reports 2020 Financial Results and Recent Advancements | Business & Finance
WATERTOWN, Mass.–(BUSINESS WIRE)–Mar 18, 2021– SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today reported full year 2020